Scholars@Duke

Role of the type III TGF-b receptor in mediating immunosuppression during breast cancer progression.

Publication ,  Conference
Hanks, BA; Lee, JD; Morse, M; Clay, TM; Lyerly, HK; Blobe, GC
Published in: Journal of Clinical Oncology
May 20, 2010
Published version (DOI) Publisher Link

Duke Scholars

Brent A. Hanks
Author Brent A. Hanks Medicine, Medical Oncology
Herbert Kim Lyerly
Author Herbert Kim Lyerly Surgery, Surgical Sciences
Gerard Conrad Blobe
Author Gerard Conrad Blobe Medicine, Medical Oncology

Published In

Journal of Clinical Oncology

DOI

10.1200/jco.2010.28.15_suppl.10577

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15_suppl

Start / End Page

10577 / 10577

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hanks, B. A., Lee, J. D., Morse, M., Clay, T. M., Lyerly, H. K., & Blobe, G. C. (2010). Role of the type III TGF-b receptor in mediating immunosuppression during breast cancer progression. In Journal of Clinical Oncology (Vol. 28, pp. 10577–10577). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2010.28.15_suppl.10577
Hanks, B. A., J. D. Lee, M. Morse, T. M. Clay, H. K. Lyerly, and G. C. Blobe. “Role of the type III TGF-b receptor in mediating immunosuppression during breast cancer progression.” In Journal of Clinical Oncology, 28:10577–10577. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.10577.
Hanks BA, Lee JD, Morse M, Clay TM, Lyerly HK, Blobe GC. Role of the type III TGF-b receptor in mediating immunosuppression during breast cancer progression. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 10577–10577.
Hanks, B. A., et al. “Role of the type III TGF-b receptor in mediating immunosuppression during breast cancer progression.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2010, pp. 10577–10577. Crossref, doi:10.1200/jco.2010.28.15_suppl.10577.
Hanks BA, Lee JD, Morse M, Clay TM, Lyerly HK, Blobe GC. Role of the type III TGF-b receptor in mediating immunosuppression during breast cancer progression. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 10577–10577.

Published In

Journal of Clinical Oncology

DOI

10.1200/jco.2010.28.15_suppl.10577

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15_suppl

Start / End Page

10577 / 10577

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences